Literature DB >> 27800612

Direct Delivery of Recombinant Pin1 Protein Rescued Osteoblast Differentiation of Pin1-Deficient Cells.

Woo-Jin Kim1, Rabia Islam1, Bong-Soo Kim1, Young-Dan Cho1, Won-Joon Yoon1, Jeong-Hwa Baek1, Kyung-Mi Woo1, Hyun-Mo Ryoo1.   

Abstract

Pin1 is a peptidyl prolyl cis-trans isomerase that specifically binds to the phosphoserine-proline or phosphothreonine-proline motifs of several proteins. We reported that Pin1 plays a critical role in the fate determination of Smad1/5, Runx2, and β-catenin that are indispensable nuclear proteins for osteoblast differentiation. Though several chemical inhibitors has been discovered for Pin1, no activator has been reported as of yet. In this study, we directly introduced recombinant Pin1 protein successfully into the cytoplasm via fibroin nanoparticle encapsulated in cationic lipid. This nanoparticle-lipid complex delivered its cargo with a high efficiency and a low cytotoxicity. Direct delivery of Pin1 leads to increased Runx2 and Smad signaling and resulted in recovery of the osteogenic marker genes expression and the deposition of mineral in Pin1-deficient cells. These result indicated that a direct Pin1 protein delivery method could be a potential therapeutics for the osteopenic diseases. J. Cell. Physiol. 232: 2798-2805, 2017.
© 2016 Wiley Periodicals, Inc. © 2016 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 27800612     DOI: 10.1002/jcp.25673

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  4 in total

Review 1.  Protein-Based Nanoparticles as Drug Delivery Systems.

Authors:  Seyoung Hong; Dong Wook Choi; Hong Nam Kim; Chun Gwon Park; Wonhwa Lee; Hee Ho Park
Journal:  Pharmaceutics       Date:  2020-06-29       Impact factor: 6.321

2.  PIN1 is a new therapeutic target of craniosynostosis.

Authors:  H R Shin; H S Bae; B S Kim; H I Yoon; Y D Cho; W J Kim; K Y Choi; Y S Lee; K M Woo; J H Baek; H M Ryoo
Journal:  Hum Mol Genet       Date:  2018-11-15       Impact factor: 6.150

Review 3.  Fibroin nanoparticles: a promising drug delivery system.

Authors:  Duy Toan Pham; Waree Tiyaboonchai
Journal:  Drug Deliv       Date:  2020-12       Impact factor: 6.419

Review 4.  RUNX2-modifying enzymes: therapeutic targets for bone diseases.

Authors:  Woo-Jin Kim; Hye-Lim Shin; Bong-Soo Kim; Hyun-Jung Kim; Hyun-Mo Ryoo
Journal:  Exp Mol Med       Date:  2020-08-13       Impact factor: 8.718

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.